Trial · NCT04735393
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | General disorders and administration site conditions | General disorders | Reproxalap (6-week) | 205 | 503 | 205 |
| other | General disorders and administration site conditions | General disorders | Vehicle (6-week) | 8 | 251 | 8 |
| other | General disorders and administration site conditions | General disorders | Reproxalap (12-month) | 127 | 299 | 127 |
| other | General disorders and administration site conditions | General disorders | Vehicle (12-month) | 3 | 148 | 3 |
| serious | Appendicitis | Infections and infestations | Reproxalap (6-week) | 0 | 503 | 0 |
| serious | Appendicitis | Infections and infestations | Vehicle (6-week) | 0 | 251 | 0 |
| serious | Appendicitis | Infections and infestations | Reproxalap (12-month) | 0 | 299 | 0 |
| serious | Appendicitis | Infections and infestations | Vehicle (12-month) | 1 | 148 | 1 |
| serious | COVID-19 Infection | Infections and infestations | Reproxalap (6-week) | 0 | 503 | 0 |
| serious | COVID-19 Infection | Infections and infestations | Vehicle (6-week) | 0 | 251 | 0 |
| serious | COVID-19 Infection | Infections and infestations | Reproxalap (12-month) | 0 | 299 | 0 |
| serious | COVID-19 Infection | Infections and infestations | Vehicle (12-month) | 1 | 148 | 1 |
| serious | Unknown cause of death | General disorders | Reproxalap (6-week) | 0 | 503 | 0 |
| serious | Unknown cause of death | General disorders | Vehicle (6-week) | 0 | 251 | 0 |
| serious | Unknown cause of death | General disorders | Reproxalap (12-month) | 0 | 299 | 0 |
| serious | Unknown cause of death | General disorders | Vehicle (12-month) | 1 | 148 | 1 |
| serious | Premature ventricular contractions | Cardiac disorders | Reproxalap (6-week) | 0 | 503 | 0 |
| serious | Premature ventricular contractions | Cardiac disorders | Vehicle (6-week) | 0 | 251 | 0 |
| serious | Premature ventricular contractions | Cardiac disorders | Reproxalap (12-month) | 0 | 299 | 0 |
| serious | Premature ventricular contractions | Cardiac disorders | Vehicle (12-month) | 1 | 148 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04735393/events